US Stock MarketDetailed Quotes

MIRA MIRA Pharmaceuticals

Watchlist
  • 1.320
  • +0.060+4.76%
Close Nov 22 16:00 ET
  • 1.340
  • +0.020+1.52%
Post 20:01 ET
21.86MMarket Cap-1910P/E (TTM)

About MIRA Pharmaceuticals Company

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.

Company Profile

SymbolMIRA
Company NameMIRA Pharmaceuticals
Listing DateAug 3, 2023
Issue Price7.00
Founded2020
CEOMr. Erez Aminov
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address1200 Brickell Avenue,Suite 1950 1183
CityMiami
ProvinceFlorida
CountryUnited States of America
Zip Code33131
Phone1-786-432-9792
Websitehttp://mirapharmaceuticals.com

Company Executives

  • Name
  • Position
  • Salary
  • Erez Aminov
  • Chairman of the Board and Chief Executive Officer
  • 1.67M
  • Michelle Yanez, M.B.A.
  • Chief Financial Officer, Secretary, Treasurer and Principal Accounting Officer
  • 541.62K
  • Ned MacPherson
  • Director
  • --
  • Dr. Matthew Paul Del Giudice, M.D.
  • Director
  • --
  • Dr. Denil Nanji Shekhat, M.D.
  • Director
  • --
  • Matthew Pratt Whalen
  • Director
  • --
  • Edward MacPherson
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data